ATNM
Actinium Pharmaceuticals Inc
1.10$
-3.6%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -8.4% | +8.5% | +1.7% | -8.6% | -6.4% | -10.7% | -8.2% | -10.9% | -7.8% | -12.2% | -11.6% | |
| – | -8.6% | +9.1% | +2.0% | -8.7% | -6.3% | -10.8% | -8.2% | -10.9% | -9.2% | -12.4% | -12.8% | |
| – | -7.6% | +9.6% | +2.4% | -8.6% | -7.3% | -10.4% | -8.3% | -10.9% | -10.1% | -12.2% | -13.4% | |
| – | -7.6% | +9.6% | +2.4% | -8.6% | -7.3% | -10.4% | -8.3% | -10.9% | -10.1% | -12.2% | -13.4% | |
| – | -0.7% | -1.3% | +3.4% | -4.6% | +0.5% | -2.7% | +2.4% | -3.7% | +3.7% | -1.8% | -77.2% | |
| – | -2.1% | -5.1% | +20.6% | -20.3% | +5.1% | -12.7% | +16.9% | -17.8% | +16.6% | -7.8% | +26.0% | |
| – | +3.6% | +1.8% | +0.0% | +1.6% | +3.6% | +1.7% | +1.7% | +1.7% | +18.4% | +1.7% | +1.6% | |
| – | -2.4% | -5.5% | +22.1% | -21.6% | +5.2% | -13.8% | +18.3% | -19.3% | – | – | +28.7% | |
| – | -16.5% | +20.6% | -0.1% | -12.8% | -14.3% | -21.6% | -26.0% | -27.5% | -43.2% | -70.6% | +1,215.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +2.1% | +0.9% | +8.0% | +3.2% | +0.4% | +0.0% | 0.0% | +0.0% | +0.0% | +0.1% | +0.5% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.